PSCA and cancer: Similarly, for the PSCA rs2976392 polymorphism, there were 18 studies exploring the relationship between this polymorphism and risk of overall cancer with 10,501 cases and 9,766 controls [12–14, 18, 20–21, 23, 28, 32, 36, 40–41, 43–44, 46–48].